Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | ACACB | O00763 | 6/20 | 0.50 |
| ▸ | ACACA | Q13085 | 3/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8323514 | 1.00 | L3MBTL1 (0.53) | L3MBTL1LMNAACACBACACACYP2C19 | |
| SCHEMBL3685401 | 0.93 | LMNA (0.57) | L3MBTL1LMNASMN1; SMN2POLBTDP1 | |
| SCHEMBL31558760 | 0.90 | LMNA (0.62) | L3MBTL1LMNAPOLBTDP1 | |
| SCHEMBL9191267 | 0.89 | LMNA (0.64) | LMNAPOLB | |
| SCHEMBL9189425 | 0.89 | LMNA (0.64) | LMNAPOLB | |
| SCHEMBL9194774 | 0.89 | LMNA (0.64) | LMNAPOLB | |
| SCHEMBL9193732 | 0.89 | LMNA (0.64) | LMNAPOLB | |
| SCHEMBL30967691 | 0.86 | ESR1 (0.50) | L3MBTL1LMNAACACBACACACYP2C19 | |
| SCHEMBL9380908 | 0.86 | RARB (0.59) | LMNASMN1; SMN2POLB | |
| SCHEMBL9380903 | 0.86 | RARB (0.59) | LMNASMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120005420-A | Disperse dye for superfine denier fiber and synthesis method thereof | 青岛大学 | 2025-05-16 | — | — | CN | disclosed |
| CN-108047033-B | Reaction device and method for preparing mandelic acid compound | 江西科苑生物药业有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-7737286-B2 | α-Hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered latone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds | KYUNG-IN SYNTHETIC CORPORATION (KR) | 2010-06-15 | — | — | US | disclosed |
| EP-1663934-A4 | ALPHA-HYDROXY-BENZENEACETIC ACID DERIVATIVES, AND COMPOUNDS HAVING TWO 5-MEMBERED LACTONE RINGS FUSED TO CENTRAL CYCLOHEXA-1,4-DIENE NUCLEUS BASED UPON THE SAME, AND USES OF THE COMPOUNDS | KYUNG IN SYNTHETIC CORP (KR) | 2008-10-01 | — | — | EP | disclosed |
| US-20070220688-A1 | Alpha-Hydroxy-Benzeneacetic Acid Derivatives, and Compounds Having Two 5-Membered Latone Rings Fused to Central Cyclohexa-1,4-Diene Nucleus Based Upon the Same, and Uses of the Compounds | KYUNG-IN SYNTHETIC CORPORATION (KR) | 2007-09-27 | — | — | US | disclosed |
| EP-1663934-A1 | ALPHA-HYDROXY-BENZENEACETIC ACID DERIVATIVES, AND COMPOUNDS HAVING TWO 5-MEMBERED LACTONE RINGS FUSED TO CENTRAL CYCLOHEXA-1,4-DIENE NUCLEUS BASED UPON THE SAME, AND USES OF THE COMPOUNDS | KYUNG-IN SYNTHETIC CORPORATION (KR) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005028409-A1 | ALPHA-HYDROXY-BENZENEACETIC ACID DERIVATIVES, AND COMPOUNDS HAVING TWO 5-MEMBERED LACTONE RINGS FUSED TO CENTRAL CYCLOHEXA-1,4-DIENE NUCLEUS BASED UPON THE SAME, AND USES OF THE COMPOUNDS | KYUNG-IN SYNTHETIC CORPORATION (KR) | 2005-03-31 | — | — | WO | disclosed |
| EP-0559345-B1 | Polycyclic dyes | BASF AG (DE) | 1999-05-06 | — | — | EP | disclosed |
| EP-0560499-B1 | Process for the preparation of polycyclic dyes | BASF AG (DE) | 1997-07-09 | — | — | EP | disclosed |
| EP-0252406-B2 | Process for the manufacture of polycyclic compounds | BAYER AG (DE) | 1996-03-20 | — | — | EP | disclosed |
| US-5281241-A | Benzo(1,2-b:4,5-b')difuran derivatives | ZENECA LIMITED (GB) | 1994-01-25 | — | — | US | disclosed |
| EP-0574148-A1 | Polycyclic dyes | ZENECA LIMITED (GB) | 1993-12-15 | — | — | EP | disclosed |
| EP-0560499-A1 | Polycyclic dyes | ZENECA LIMITED (GB) | 1993-09-15 | — | — | EP | disclosed |
| EP-0559345-A1 | Polycyclic dyes | ZENECA LIMITED (GB) | 1993-09-08 | — | — | EP | disclosed |
| EP-0551725-A1 | Polycyclic dyes | ZENECA LIMITED (GB) | 1993-07-21 | — | — | EP | disclosed |
| US-5220040-A | Furan and monoazo dyes having similar wavelength maxima; efficient package dyeing of wound polyester | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-06-15 | — | — | US | disclosed |
| EP-0492893-A2 | Mixtures and mixed crystals of dyes | ZENECA LIMITED (GB) | 1992-07-01 | — | — | EP | disclosed |
| EP-0252406-A2 | Process for the manufacture of polycyclic compounds | BAYER AG (DE) | 1988-01-13 | — | — | EP | disclosed |
| EP-0033583-B1 | DYESTUFFS COMPRISING TWO 5-MEMBERED HETEROCYCLIC NUCLEI FUSED TO A CENTRAL CYCLOHEXADIENE NUCLEUS, PROCESSES FOR THEIR PREPARATION AND THEIR USE FOR COLOURING SYNTHETIC TEXTILE MATERIALS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-10-12 | — | — | EP | disclosed |
| EP-0033583-A1 | Dyestuffs comprising two 5-membered heterocyclic nuclei fused to a central cyclohexadiene nucleus, processes for their preparation and their use for colouring synthetic textile materials | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070220688-A1 | Alpha-Hydroxy-Benzeneacetic Acid Derivatives, and Compounds Having Two 5-Membered Latone Rings Fused to Central Cyclohexa-1,4-Diene Nucleus Based Upon the Same, and Uses of the Compounds | LDHA, HCAR1, HPD | L3MBTL1 3566/4885LMNA 79/4885ACACB 561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.